Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Sun Pharmaceutical Industries LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524715NSE Symbol: SUNPHARMAP/E(TTM):99.67
ISIN Demat:INE044A01036Div & Yield %:0.88EPS(TTM):18.19
Book Value(Rs):99.2482659Market Cap ( Cr.):434999.43Face Value(Rs):1
    Change Company 
Date Headline
04-Feb-26 Sun Pharmaceutical Industries Ltd soars 0.55%, rises for fifth straight session
01-Feb-26 Indices trade sideways; breadth positive
01-Feb-26 Sun Pharma gains as Q3 PAT jumps 16% YoY to Rs3,369 cr
01-Feb-26 Sensex, Nifty plunge amid STT hike in Budget 2026; PSU Bank shares skid
31-Jan-26 Sun Pharmaceutical Industries consolidated net profit rises 16.03% in the December 2025 quarter
31-Jan-26 Board of Sun Pharmaceuticals Industries recommends interim dividend
31-Jan-26 Sun Pharma Q3 PAT jumps 16% YoY to Rs3,369 cr
23-Jan-26 Sun Pharma receives DCGI approval for generic version of semaglutide injection
21-Jan-26 Sun Pharmaceuticals Industries to convene board meeting
20-Jan-26 Sun Pharmaceutical Industries fixes record date for dividend
<< < 1 2 3 4   > >>